PT Brigit Biofarmaka Technologi Tbk (OBAT) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of PT Brigit Biofarmaka Technologi Tbk stock IDR 702, price IDR 244, upside +187.7%, quality 58 out of 100. Rating: strongly undervalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
PT Brigit Biofarmaka Technologi Tbk
OBAT · JKCheap (65% below fair value) and solid company, but falling price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
22‑month range 193.00 IDR – 833.48 IDR · fair‑value band 320.27 IDR – 877.38 IDR · the 244.00 IDR price screens below the 701.90 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether PT Brigit Biofarmaka Technologi Tbk is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
PT Brigit Biofarmaka Technologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia.
Show moreShow less
It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, and hair serum and powder, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products.
In addition, it provides lip gloss, cushion, foundation, eyeliner, and blush on balm. The company was founded in 2015 and is based in Sukoharjo, Indonesia.
Stock analysis
PT Brigit Biofarmaka Technologi Tbk (OBAT) currently trades at 244.00 IDR, while our model-based Fair Value estimate is 701.90 IDR, implying the stock looks roughly 65% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 1,546 IDR per share, and 17 of the 22 models we run sit above the 244.00 IDR price.
Bear case: the Asset-Based group reads lowest at 72.04 IDR, and 5 of the 22 models stay below the price. Data coverage for this calculation is low.
Scenario range: 320.27 IDR (bear) to 877.38 IDR (bull), the price of 244.00 IDR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
PT Brigit Biofarmaka Technologi Tbk reported revenue of 160B IDR in FY2025 versus 56.9B IDR in FY2023, a compound +67.7%/yr. Reported net income was 22.6B IDR in FY2025, compounding +37.5%/yr from FY2023.
Key figures
Market cap 172B IDR (≈ $9.4M) Micro · P/S ratio 0.97 · Dividend yield 8.0% · Net margin 7.1% · Return on equity 12.7% · Return on assets (EBIT) 40.8% (3-year average) · Operating margin 13.8% · Revenue (TTM) 173B IDR.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 61 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 0% fair-value upside, at 188%, OBAT screens cheaper than that median.
Fair Value models
All 22 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch OBAT, get fair value alerts →
Compare PT Brigit Biofarmaka Technologi Tbk with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 663 stocks
Valuation Multiplesvs Packaged Foods median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- PEG screener for stocks with fair value
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Wilmar International Limited F34 | 2.90 SGD | 4.94 SGD | +70% | vs OBAT |
| Inner Mongolia Yili Industrial Group 600887 | ¥32.20 | ¥41.84 | +30% | vs OBAT |
| The Kraft Heinz Company KHC | $25.07 | $29.20 | +16% | vs OBAT |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.76 | ¥38.07 | +6% | vs OBAT |
| General Mills, Inc GIS | $35.24 | $35.30 | +0% | vs OBAT |
| Danone S.A BN | €70.66 | €50.65 | −28% | vs OBAT |
| Nestlé S.A NESN | CHF 88.12 | CHF 59.51 | −32% | vs OBAT |
| Kerry Group KRZ | €101.80 | €60.33 | −41% | vs OBAT |
| Nestlé India Limited NESTLEIND | ₹1,297 | ₹724.74 | −44% | vs OBAT |
| Yihai Kerry Arawana Holdings 300999 | ¥25.32 | ¥12.21 | −52% | vs OBAT |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is PT Brigit Biofarmaka Technologi Tbk (OBAT) overvalued or undervalued?
What is the fair value of OBAT?
What is the quality score of OBAT?
What is the price target for PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the PT Brigit Biofarmaka Technologi Tbk stock forecast for 2026?
What is the revenue of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
Does PT Brigit Biofarmaka Technologi Tbk pay a dividend?
How much is the dividend of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the intrinsic value of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
Is PT Brigit Biofarmaka Technologi Tbk stock overvalued or undervalued in 2026?
Is fair value the same as the market price of OBAT?
How much is PT Brigit Biofarmaka Technologi Tbk worth?
What do the bullish and bearish scenarios say about OBAT?
How solid is the balance sheet of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
How far is OBAT from its 52-week high?
Which stocks are comparable to PT Brigit Biofarmaka Technologi Tbk?
Is PT Brigit Biofarmaka Technologi Tbk stock attractive at the current price?
How is the fair value of OBAT calculated?
Is it still worth investing in stocks now?
What is the share price of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What should I pay attention to with PT Brigit Biofarmaka Technologi Tbk right now?
Key figures of PT Brigit Biofarmaka Technologi Tbk
How large is the market capitalisation of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the P/S ratio of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the dividend yield of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the net margin of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the return on equity of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the EBIT return on assets of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
What is the operating margin of PT Brigit Biofarmaka Technologi Tbk (OBAT)?
How fast is revenue growing at PT Brigit Biofarmaka Technologi Tbk (OBAT)?
How fast are earnings growing at PT Brigit Biofarmaka Technologi Tbk (OBAT)?
Watch PT Brigit Biofarmaka Technologi Tbk in the live analysis
One click puts PT Brigit Biofarmaka Technologi Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.